Cefdinir
Product Images NDC 53002-2654

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 53002-2654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cefdinir Str)

Chemical structure diagram of the active ingredient Cefdinir, showing its molecular composition and connectivity including sulfur, nitrogen, oxygen, and carbon atoms arranged in characteristic rings and side chains.*

FDA Label Image

Label Image (Lbl530022654)

Cefdinir oral suspension 125 mg/5 mL in a 100 mL bottle, labeled by RPK Pharmaceuticals, Inc. The label includes directions for use every 12-24 hours until finished, with space for patient, clinic, and prescription information. It also shows lot number, expiration date, and barcode details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.